Norway COVID-19 Vaccine Deaths Draw Global Attention
No Cases Of Death In Elderly Attributed To Comirnaty Vaccination Till Date, Says EMA.
Reports from Norway about deaths in very frail, elderly patients soon after receiving Pfizer/BioNTech’s COVID-19 jab have drawn regulatory scrutiny. While the European Medicines Agency has launched an investigation, Australia is examining the need for specific warnings about risks of vaccination in the very frail elderly or terminally ill patients.
You may also be interested in...
Coronavirus Notebook: EU Publishes AstraZeneca Vaccine Contract, Implements Export Authorization Scheme
The AZ vaccine gets the regulatory go-ahead for use in the EU and the European Medicines Agency says an analysis of data on Pfizer/BioNTech’s Comirnaty has shown no new safety concerns.
Coronavirus Notebook: EMA Data Hack Aimed At 'Undermining Trust' In Vaccines, Russia Plans EU Sputnik V Filing Next Month
France has reported on side-effect reports concerning the Pfizer/BioNTech vaccine, and the World Health Organization has warned that plans to provide global equitable access to coronavirus vaccines are at risk.
The UK has used a special legislative process to temporarily authorize the use of the BNT-162b2 vaccine, with the first 800,000 shots expected to be delivered within days.